Pipeline View.

Product/Indication
Phase I
Phase II
Phase III
Status
Product/Indication
NRCx-201
Treatment Resistant Depression
Phase I
Phase II
Phase III
Status
Suitable for Phase III submission with MHRA
Product/Indication
NRCx-201
Bipolar Depression
Phase I
Phase II
Phase III
Status
Study to commence in 2025
Product/Indication
NRCx-201
Anorexia – Depression
Phase I
Phase II
Phase III
Status
Under Consideration for Collaborative Development

Clinical Indications.

Brain key icon

Depression

Depression is a common but serious condition that affects how a person feels, thinks, and goes about their daily life. It can cause long-lasting sadness, low energy, trouble sleeping or eating, and difficulty concentrating or enjoying things. Also known as major depression or clinical depression, it affects about 1 in 6 adults and often gets in the way of work, relationships, and overall wellbeing. While many people improve with standard treatments, some find little relief after repeated attempts— this is known as treatment-resistant depression.

Head with up and down arrow icon

Bipolar Depression

Bipolar depression is a phase of bipolar disorder where someone experiences deep lows, similar to major depression. These episodes can include sadness, fatigue, and loss of interest, making it hard to function day to day. What makes bipolar disorder unique is that these lows may be followed by periods of high energy or mania. Many people with bipolar depression struggle to find effective treatments, as options are limited and responses can vary.